Abstract
IntroductionThe prognosis of malignant pleural mesothelioma (MPM) is poor, with a median survival of 8–12 months. The ability to predict prognosis in MPM would help clinicians to make informed decisions...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have